Oura’s $2.2bn IPO is largely an exit for existing shareholders

Oura and its shareholders plan to sell 50mn shares at $40–$44, valuing the smart-ring company at as much as $15.6bn and raising up to $2.2bn. Existing holders—including early backer Forerunner—are supplying most of the stock, so the headline proceeds substantially represent liquidity for current owners rather than fresh operating capital.

The underlying business is stronger than many recent wearable offerings. Revenue rose 74% in the first nine months of the year to about $1.2bn, net income reached $60.8mn and Oura expects 5.7mn paying members by year-end. The subscription attached to the ring gives it recurring revenue beyond hardware replacement cycles. Eli Lilly, already an investor, has indicated interest in buying another $100mn of shares.

The secondary-heavy structure changes what the IPO signals. Insiders may simply be diversifying after years in a private company, and a liquid float requires sellers. But new investors should distinguish demand for Oura's growth capital from demand to cash out existing stakes. At the top of the range, the valuation assumes that health subscriptions, new sensors and medical partnerships can sustain rapid growth after the early-adopter market matures.